ProfileGDS4459 / ENSG00000180869
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 13% 6% 16% 10% 14% 22% 12% 13% 10% 18% 8% 9% 14% 2% 14% 10% 24% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.0113
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.716
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.6916
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.9910
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.7314
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.3322
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.5212
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.5713
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.3410
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.9618
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.518
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.229
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.714
GSM623477group B, liver allograft wedge biopsie placebo treatment 42.222
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.5514
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.9110
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.5324